E.g., 11/12/2025
E.g., 11/12/2025
Title Category Credit Event datesort descending List Price
Highlights from AUA2025: Advances in NMIBC (2025)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Highlights from AUA2025: Advances in NMIBC will discuss the best in the latest advancements in Non-Muscle Invasive Bladder Cancer (NMIBC) from the AUA Annual Meeting!
The Evolving Landscape of Advanced Prostate Cancer Treatment: A Guidelines and Case-Based Discussion Webcast (2025)
    • 4.00 AMA PRA Category 1 Credit™
    • 4.00 Non-Physician Participation
$0.00 This comprehensive, interactive course equips urologic professionals with the knowledge and skills needed to effectively manage patients with advanced prostate cancer. Through an in-depth exploration of guidelines, treatment modalities, and emerging therapies, participants will gain a thorough understanding of this complex disease and its evolving landscape. ACKNOWLEDGEMENTS:This educational activity is supported by independent educational grants from:
Integration of Biomarkers, MRI and PSMA PET Imaging Into the Management of Prostate Cancer Webcast (2025)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00
Embracing Multi-Disciplinary Care for Advanced Prostate Cancer: A Case-Based Update Webcast (2025)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 This is an ongoing course on advanced prostate cancer at the annual AUA since 2012 and the changes over the last decade continue to be breathtaking! In the early years, it was all about metastatic castrate-resistant prostate cancer (mCRPC) with multiple new therapeutic advances starting in 2010 followed by novel oral antiandrogens and a focus on bone-targeted agents. Later, it expanded to cover hormone sensitive (HS) advanced disease due to the new data on chemotherapy and androgen synthesis inhibitors extending survival in new M1 patients.
Update Series (2025) Lesson 29: Patient Financial Burden in Urologic Cancer and Cancer Care
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Audio Lessons - Listen on-the-go for Free!Did you know you can stream Update Series lessons from your favorite Podcast app (including Apple Podcast and Pocket Casts)?Add the Update Series Audio Lessons to Your Podcast Library Today!Please follow the download instructions to your preferred Podcast app, located below. 
Update Series (2025) Lesson 30: Beyond UPJ: Case-based Tips and Tricks in Robotic Reconstructive Surgery
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Audio Lessons - Listen on-the-go for Free!Did you know you can stream Update Series lessons from your favorite Podcast app (including Apple Podcast and Pocket Casts)?Add the Update Series Audio Lessons to Your Podcast Library Today!Please follow the download instructions to your preferred Podcast app, located below. 
Update Series (2025) Lesson 31: Ejaculatory Preserving Treatments for BPH
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Audio Lessons - Listen on-the-go for Free!Did you know you can stream Update Series lessons from your favorite Podcast app (including Apple Podcast and Pocket Casts)?Add the Update Series Audio Lessons to Your Podcast Library Today!Please follow the download instructions to your preferred Podcast app, located below. 
Update Series (2025) Lesson 32: Reconstructive Surgery in Radiated Patients
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Audio Lessons - Listen on-the-go for Free!Did you know you can stream Update Series lessons from your favorite Podcast app (including Apple Podcast and Pocket Casts)?Add the Update Series Audio Lessons to Your Podcast Library Today!Please follow the download instructions to your preferred Podcast app, located below. 
Update Series (2025) Lesson 33: Urologic Complications of Renal Transplantation
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Audio Lessons - Listen on-the-go for Free!Did you know you can stream Update Series lessons from your favorite Podcast app (including Apple Podcast and Pocket Casts)?Add the Update Series Audio Lessons to Your Podcast Library Today!Please follow the download instructions to your preferred Podcast app, located below. 
Update Series (2025) Lesson 34: Management of Extra-gonadal Germ Cell Tumors
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Audio Lessons - Listen on-the-go for Free!Did you know you can stream Update Series lessons from your favorite Podcast app (including Apple Podcast and Pocket Casts)?Add the Update Series Audio Lessons to Your Podcast Library Today!Please follow the download instructions to your preferred Podcast app, located below. 
Update Series (2025) Lesson 35: Salvage Treatment after Failed Primary Nonsurgical Therapy for Localized Prostate Cancer: A Case Based Approach
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Audio Lessons - Listen on-the-go for Free!Did you know you can stream Update Series lessons from your favorite Podcast app (including Apple Podcast and Pocket Casts)?Add the Update Series Audio Lessons to Your Podcast Library Today!Please follow the download instructions to your preferred Podcast app, located below. 
AUA Advanced Prostate Cancer Course Webcast (2025)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 This course will be focused on comprehensive AUA/SUO Guidelines on APC in the management and outcomes of men with biochemical recurrence, locally advanced, metastatic HSPC and CRPC. The course will include risk stratification, germline testing, PET imaging, the use of ADT in combination with novel androgen axis therapy and chemotherapy in men with newly diagnosed advanced and mHSPC. Early treatment intensification and evidenced based guidelines will be covered. The course will also cover non-metastatic CRPC, and treatment for mCRPC.
Incorporating Genomic Testing and Advanced Imaging for Prostate Cancer Into Your Practice Webcast (2025)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 There are multiple genomic tests and advanced imaging modalities (MRI, PSMA PET, etc) currently available for men to detect and risk stratify prostate cancer. The outcomes of these tests may lead to different detection strategies (observation, immediate biopsy, etc) and treatment decisions (active surveillance, surgery, radiation, adjuvant therapy, etc). We will also discuss germline testing as inherited mutations have considerable implications for screening, treatment, genetic counseling, and cascade testing of family members.
AUA Guidelines on Early Detection of Prostate Cancer: Maximizing Benefits, Minimizing Harm Webcast (2025)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Prostate cancer detection remains one of the most common and most controversial aspects of urologic practice. In addition to the complexities around screening and use of PSA, the role of other biomarkers, biopsy techniques such as transperineal biopsy, and MRI for targeted biopsy are evolving rapidly. This course is intended for urologists, advanced practice providers, and trainees interested in using the most evidence-based methods for optimizing detection of clinically important prostate cancers, while improving patient experience and minimizing complications.
Non-Muscle Invasive Bladder Cancer Treatment Dilemmas: The Cases You Face and How Best to Treat Them Webcast (2025)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 The course will highlight recent updates to AUA, European Association of Urology, and National Comprehensive Cancer Network Guidelines in the rapidly evolving field of bladder cancer before working through challenging but common case scenarios that will outline important changes as well as concepts essential in providing evidence-based care.ACKNOWLEDGEMENTS:This educational activity is supported by an independent educational grants from:Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Pages